Is NCT06706817 recruiting in Chestnut Hill, MA?

Yes, NCT06706817 is currently recruiting participants at its Chestnut Hill, MA location. This nasal polyps clinical trial is actively enrolling qualified participants.

How do I join the nasal polyps clinical trial in Chestnut Hill?

To join this clinical trial in Chestnut Hill, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Chestnut Hill clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Chestnut Hill, MANCT06706817Now EnrollingIRB Ready

Nasal Polyps Clinical Trial in Chestnut Hill, MA

Access cutting-edge nasal polyps treatment through this clinical trial at a research site in Chestnut Hill. Study-provided care at no cost to qualified participants.

Expert Care in Chestnut Hill

Access nasal polyps specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related nasal polyps treatment provided free

Apply for This Chestnut Hill Location

Check if you qualify for this nasal polyps clinical trial in Chestnut Hill, MA

Why Participate?

No-Cost Study Care
Local to Chestnut Hill
Convenient for MA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

1Submit this form
2Phone screening
3Visit Chestnut Hill site if eligible
4Begin participation

About This Nasal Polyps Study in Chestnut Hill

The main objective of this study is to evaluate treatment outcomes of tezepelumab among participants with physician-determined surgery-eligible CRSwNP, with or without asthma. Study details include: 1. The study duration will be up to 40 weeks. 2. The treatment duration will be up to 24 weeks. 3. The visit frequency will be once every 4 weeks (Q4W).

Sponsor: AstraZeneca

Who Can Participate

Inclusion Criteria

Participants must be 18 years of age or older, at the time of signing the informed consent.

Participants with physician-diagnosed CRSwNP for at least 12 months prior to Visit 1 who have all of the following:

Severity consistent with the need for surgery as defined by total NPS ≥ 4 (at least 2 for each nostril) at screening, as determined by the central reader

Mean NCS ≥ 2 in the 2 weeks prior to Visit 2

Ongoing documented NP symptoms for \> 8 weeks prior to screening such as rhinorrhoea, reduction or loss of smell and/or poor quality/loss of sleep

SNOT-22 total score ≥ 30 as assessed at screening. Note: approximately 50 participants with a NPS = 4 at screening will receive treatment with tezepelumab.

Any standard of care for treatment of CRSwNP, which must include treatment with intranasal corticosteroids, provided the participant is stable on that treatment for at least 30 days prior to Visit 1. Investigators should also assure that participants are

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chestnut Hill?

Yes, this clinical trial (NCT06706817) has an active research site in Chestnut Hill, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Nasal Polyps Treatment Options in Chestnut Hill, MA

If you're searching for nasal polyps treatment options in Chestnut Hill, MA, this clinical trial (NCT06706817) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chestnut Hill research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nasal polyps specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all nasal polyps clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Chestnut Hill, MA

See all ankylosing spondylitis clinical trials recruiting in Chestnut Hill — not just this study.

Browse Ankylosing Spondylitis Trials in Chestnut Hill →

Browse More Trials by Condition

Ankylosing Spondylitis Trials All Conditions →

Ready to Join in Chestnut Hill?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chestnut Hill, MA